Biography
Louis Aledort is a board-certified internist and hematologist who began his Mount Sinai career in 1966. A former Dean for Faculty and Hospital Affairs at Mount Sinai School of Medicine, Dr. Aledort has been The Mary Weinfeld Professor of Clinical Research in Hemophilia since 1993. Dr. Aledort earned his medical degree at the Albert Einstein College of Medicine of Yeshiva University as a member of its first graduating class, in 1959. He continued his studies as a resident at the University of Virginia and at Strong Memorial Hospital in Rochester, NY, where he also had a Hematology Fellowship. From Rochester, Dr. Aledort joined Mount Sinai, where he has remained for 45 years. A pioneer in the study and treatment of coagulation disorders, Dr. Aledort continues to be the one of the world’s leading authorities on hemophilia. He has long been at the forefront of developing comprehensive care for hemophilia, including creating The Mount Sinai Regional Comprehensive Hemophilia Treatment Center, which has been designated as a World Health Organization Global Cooperating Training Center in Coagulation Diseases. He has been involved in this field for over 50 years, through his academic research and community and service efforts. Dr. Aledort has been a leader in the design and implementation of several groundbreaking collaborative study groups, including the U.S. Hemophilia Study Group, the Transfusion Safety Study, and the Orthopedic Outcome Study. He has authored more than 400 peer-reviewed articles in prominent journals, including Haemophilia, Journal of Thrombosis and Haemostasis, and the American Journal of Hematology.
Research Interest
Dr. Aledort's research interests include: White cell disorders, Red cell disorders, Platelet disorders, Vasculitis, Thrombosis, and Bleeding.
Related Publications
-
Immunoglobulins And CLL- Any Association- Serum Immunoglobulin Levels And CLL-Is There A Prognostic Association
Research Article: J Blood Res Hematol Dis 2018, 3:1
DOI:
Zing NPC, Fischer T, Fortier SC, Bueno da Silveira TM and Chiattone CS
-
Autoimmune Diseases And Rosai- Dorfman Disease Coexist More Commonly Than Expected
Case Report: J Blood Res Hematol Dis 2018, 3:1
DOI:
Lia NL, Asad SD, Jafri SI and Harrison JS
-
Effect of Haemodialysis on Some Haematological Parameters in Patients with End-Stage Renal Failure
Research Article: J Blood Res Hematol Dis 2018, 3:1
DOI:
Momodu I, Hamidatu JM, Makursidi MA and Galadima DA
-
Prevalence, Severity and Determinants of Anemia among Pregnant Women at Antenatal Clinics in Masasi District, Tanzania
Research Article: J Blood Res Hematol Dis 2018, 3:1
DOI:
Nyandiva O, Yogas G, Chikomele JR and Mghanga FP
-
Acquired Amegakaryocytic Thrombocytopenic Purpura: A Masquerader of Immune Thrombocytopenic Purpura
Case Report: J Blood Res Hematol Dis 2018, 3:1
DOI:
Ho S, Gowan JM and Javdan F
-
Evaluation of Anticoagulant and Antiplatelet Activity of Pisum sativum Pod Extract
Research Article: J Blood Res Hematol Dis 2017, 2:1
DOI:
Chethana Ramachandraiah, Sharath Kumar M Nandish, Jayanna Kengaiah, Ashwini Shivaiah, Chandramma, Kesturu S.Girish, Kempaiah Kemparaju and Devaraja Sannaningaiah
-
Haemophilia B PMS1 Gene SNPs Predictions through Insilico Approach at Proteomics Levels
Research Article: J Blood Res Hematol Dis 2017, 2:1
DOI:
Hiba Siddig Ibrahim
-
Optimal Therapy for Polycythemia Vera and Essential Thrombocythemia: A Different Perspective
Editorial: J Blood Res Hematol Dis 2015, 1:1
DOI:
Richard T Silver and Hans Carl Hasselbalch
-
Recent Advances in Hodgkin Lymphoma
Editorial: J Blood Res Hematol Dis 2016, 1:2
DOI:
Theodoros P Vassilakopoulos and Sotirios G Papageorgiou
-
Characterization of Complex Chromosomal Rearrangements in Acute Myeloid Leukemia: FISH and Multicolor FISH Add Precision in Defining Abnormalities Associated with Poor Prognosis
Research Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Pina J Trivedi, Dharmesh M Patel, Manisha M Brahmbhatt and Prabhudas S Patel
-
Caring for a Sick Child
Editorial: J Blood Res Hematol Dis 2016, 1:1
DOI:
Luisa M Massimo
-
Relationship between Cellular Senescence and Redox Potential on Adult T-Cell Leukemia Cells
Short Communication: J Blood Res Hematol Dis 2016, 1:1
DOI:
Yasuhiro Maeda, Atsushi Okamoto, Shin-ichiro Kawaguchi, Akiko Konishi, Kenta Yamamoto, Go Eguchi and Terufumi Yamaguchi
-
EHPVO and Splanchnic Vein Thrombosis
Review Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Afaq Ahmad Khan, Zeeshan Ahmad Wani, Tufeel Kochak and Sonmoon Mohapatra
-
Autoimmune Thyroid Disease in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms Treated with Interferon-Alpha
Research Article: J Blood Res Hematol Dis 2016, 1:1
DOI:
Cecilie Paulsrud, Hans C Hasselbalch and Ole Weis Bjerrum
-
Efficiency of Pre-Storage Leukoreduction of Red Cells: A Double Blind Quality Control Method, Transfusion medicine
Letter to Editor: J Blood Res Hematol Dis 2016, 1:2
DOI:
Setia Rasika, Arora Satyam, Handoo Anil and Kapoor Meenu
-
Timely Dosage Dependent Ethanolic Extract of Mangifera Indica Promotes Blood Cells Development and Weight Gain
Research Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Jimmy EO and Udo ES
-
The Role of Wnt/β -Catenin Signaling in Normal and Malignant Hematopoiesis, Hemostasis
Review Article: J Blood Res Hematol Dis 2016, 1:1
DOI:
Teresa Sadras, Richard J D’Andrea and Deborah L White